Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.
Saved in:
| Title: | Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis. |
|---|---|
| Authors: | El Raziky, M.1 maelraziky@yahoo.com, Gamil, M.2, Ashour, M. K.1, Sameea, E. A.3, Doss, W.4, Hamada, Y.1, Van Dooren, G.2, DeMasi, R.5, Keim, S.6, Lonjon‐Domanec, I.7, Hammad, R.4, Hashim, M. S.3, Hassany, M.4, Waked, I.3 |
| Source: | Journal of Viral Hepatitis. Feb2017, Vol. 24 Issue 2, p102-110. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13520504 |
|---|---|
| DOI: | 10.1111/jvh.12625 |